Search

Home > ACC CardiaCast > CardiaCast: New Hope in HF: The Evolving Evidence for SGLT2 Inhibitors
Podcast: ACC CardiaCast
Episode:

CardiaCast: New Hope in HF: The Evolving Evidence for SGLT2 Inhibitors
Category: Science & Medicine
Duration: 00:16:35
Publish Date: 2021-07-30 13:00:00
Description:

In this episode, Alanna Morris, MD, MSc, FACC; Javed Butler, MBBS, FACC; John McMurray, MD, FACC; and Muthiah Vaduganathan, MD, FACC, discuss the role of sodium-glucose transport protein 2 inhibitors in the new hope in heart failure (HF). Visit the Clinical Spotlight Series: Shining a Light on New HF Pharmacotherapies online course page for more information and resources. Educational Support provided by AstraZeneca, Cytokinetics, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.
Total Play: 0